• Griseofulvin: From Antifungal Action to Assay Design

  2026-08-23

  Griseofulvin is a microtubule associated inhibitor with value beyond conventional antifungal drug research. This article shows how compound handling, multiparameter flow cytometry, and mechanistic controls can improve interpretation of fungal cell mitosis inhibition and aneugenicity studies.

• Baicalin methyl ester for Intestinal Barrier Assays

  2026-08-22

  Baicalin methyl ester provides a mechanistically focused tool for modeling LPS-induced intestinal barrier damage, linking inflammatory signaling with tight-junction and epithelial-readout assays. This guide translates product specifications into practical cell, dosing, solubility, troubleshooting, and translational workflows.

• Flavopiridol: Separating CDK and ER Stress Effects

  2026-08-21

  Flavopiridol (L868275) is examined as a cell cycle arrest agent through a new assay framework that separates direct CDK inhibition from endoplasmic reticulum stress. The article translates intestinal stem cell findings into practical decisions for cancer research, pathway validation, and mechanistic interpretation.

• Tolazoline: From Receptor Binding to Translation

  2026-08-20

  Tolazoline is a mechanistically useful α2-adrenergic receptor antagonist for connecting receptor pharmacology with airway and islet phenotypes. This thought-leadership guide explains how to separate receptor-mediated effects from higher-concentration ATP-sensitive potassium channel activity, design orthogonal assays, and interpret translational evidence without overstating potency or clinical relevance.

• LAMP1, CXCL10–CXCR3, and Macrophage Polarization

  2026-08-20

  The 2024 International Immunopharmacology study identifies LAMP1 as a context-dependent regulator of CXCL10–CXCR3 signaling in macrophages. Its experiments show that the same chemokine axis can favor different polarization states in non-inflammatory and poly(I:C)-stimulated cells, while CXCR3 blockade with AMG487 reduced lung injury in a mouse model.

• PARP1/FAK/COL5A1 Signaling in Ovarian Cancer

  2026-08-19

  The reference study shows that prolonged cholesterol exposure can produce a cholesterol-resistant ovarian cancer state in which PARP1 activates FAK/Src/COL5A1 signaling and promotes epithelial–mesenchymal transition. Its combination of long-term adaptation, mechanistic perturbation, tissue analysis, and in vivo validation provides a useful framework for studying cholesterol-linked tumor progression.

• Ratiometric Imaging of Amyloid-β Fibrils with Ru(II)

  2026-08-19

  The 2024 Inorganic Chemistry study introduces dual-emissive tris-heteroleptic ruthenium complexes for ratiometric detection and confocal imaging of amyloid-β fibrils. Complex 2 combines a stable fluorescence reference with aggregation-responsive phosphorescence, improving measurement reliability while revealing stronger interactions with Aβ40 fibrils than with Aβ42 fibrils.

• Dissolving Microneedles for Risedronate Delivery

  2026-08-18

  A 2023 International Journal of Pharmaceutics study developed a dissolving microneedle patch containing Risedronate Sodium and Ursolic Acid in bipartite nanotransfersomes. The optimized system produced nanoscale vesicles, sustained dual-drug release, and substantial ex vivo skin permeation, providing a promising formulation strategy for osteoporosis research while still requiring in vivo and clinical validation.

• ISRIB and Accelerated Forgetting in Epilepsy

  2026-08-18

  A 2025 Molecular Neurobiology study identifies integrated stress response activation as a mechanism linking physiological forgetting with epilepsy-associated accelerated forgetting. In mouse recognition-memory paradigms, repeated ISRIB treatment during memory retention prevented established memories from being lost and corrected seizure-associated forgetting, while a single treatment did not alter retrieval.

• Hexetidine NSC-17764 Biofilm Assay Workflows

  2026-08-17

  Build more informative antimicrobial screens with Hexetidine (NSC-17764), from strain-specific planktonic MIC testing to age-resolved PVC biofilm experiments. This workflow combines oral infection relevance with practical controls for solvent handling, biofilm maturity, kill kinetics, and assay interpretation.

• (S)-(+)-Methoprene: JH Signaling Research

  2026-08-17

  (S)-(+)-Methoprene is a juvenile hormone analog that activates the insect juvenile hormone receptor pathway and supports controlled studies of hormone-regulated development in insects. Its defined molecular identity, solvent compatibility, and arthropod-focused activity make it useful for receptor biology, metamorphosis assays, and endocrine-disruption research when experimental stage and species are controlled.

• Minoxidil sulphate in Vascular Research

  2026-08-16

  Minoxidil sulphate is a practical activation probe for connecting potassium-channel biology with vascular reactivity and hair follicle assays. This workflow-led guide shows how to prepare the compound, separate activation effects from channel-blocker phenotypes, and troubleshoot solubility, vehicle, and tissue variability.

• Bile Acid Retention and Immune Escape in MASH-HCC

  2026-08-15

  The reference study identifies a GPR120–bile acid–NLRC5 pathway that links lipid-associated metabolic stress to defective MHC-I antigen presentation in MASH-HCC. Its findings suggest that restoring bile acid regulation with an FXR agonist may improve tumor immunogenicity and enhance anti-PD-1 responses, although the mechanism remains preclinical.

• Pseudo-UTP: Engineering Better mRNA Translation

  2026-08-15

  Pseudo-UTP is more than a UTP substitute: it is a design variable that can influence RNA persistence, translation, and innate immune recognition. This thought-leadership guide connects pseudouridine biochemistry with vaccine evidence, IVT strategy, product selection, and translational decision-making.

• Mubritinib (TAK 165): From OXPHOS to Antivirals

  2026-08-14

  Mubritinib (TAK 165) is best understood as a context-dependent metabolic probe rather than only a HER2 inhibitor. This article explains how its complex I activity, AML and PEL selectivity, and in vitro orthopoxvirus findings should shape rigorous assay design and interpretation.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page